Courtesy Roswell Park Cancer Talk Blog Although we do not usually associate the occurrence of cancer with young adults, it is the number one cause of disease-related death among people ages 15-39. In fact, young adults get rare and aggressive forms of cancer, but when symptoms arise,
Read more →
Cancer treatment is likely to affect every aspect of a patient’s life — their activities, relationships, eating habits, mental health, physical health and comfort, financial wellbeing. And when financial concerns weigh heavily on an individual who is in treatment for cancer, they can affect the outcome of
Read more →
A multidisciplinary research team led by Song Yao, PhD, Professor of Oncology in the Department of Cancer Prevention and Control at Roswell Park Comprehensive Cancer Center and Kara Kelly, MD, Chair of the Roswell Park Oishei Children’s Cancer and Blood Disorders Program, has received a critical grant
Read more →
Today, Roswell Park Comprehensive Cancer Center and the Bristol Myers Squibb Foundation announced a $3.3 million program to address the cancer burden in rural areas and Native Nations across New York State, with an emphasis on the Western New York region. The grant from the Bristol Myers
Read more →Roswell Park Comprehensive Cancer Center’s Chief of Myeloma, Jens Hillengass, MD, is slated to speak at the National Comprehensive Cancer Network (NCCN) 2020 Virtual Congress on Hematologic Malignancies, happening October 9 and 10. Dr. Hillengass, a member of the NCCN’s Guidelines Panel for Multiple Myeloma, will present on “Evolving Concepts
Read more →Ellis Medicine and Roswell Park Comprehensive Cancer Center marked a major milestone today with the announcement of an affiliation that will bring new medical oncology services to Ellis Hospital. Ellis is creating a medical oncology/chemotherapy/infusion center at the hospital—and through the affiliation, will expand local access to
Read more →Elected by a body of fellow immunotherapy researchers from across the globe, Roswell Park Comprehensive Cancer Center Deputy Director Kunle Odunsi, MD, PhD, FRCOG, FACOG, has been named an At-Large Director for the Society for Immunotherapy of Cancer (SITC) Board of Directors. The nonprofit organization’s members voted
Read more →
The Ride for Roswell Announces Summer Riding Locations. **In-person, scheduled rides will be held weekends August 1-21 and be held at Linde, UB, Grand Island, and Akron. The Ride for Roswell, presented by the West Herr Automotive Group, is excited to announce the locations and details for
Read more →Roswell Park Team Proposes Strategy for Making Pancreatic Tumors Respond to Checkpoint Inhibition New study provides rationale for combining targeted therapies with anti-PD-L1 immunotherapy Most pancreatic cancers do not respond to immune checkpoint inhibitors In lab, combination of CDK4/6 inhibitors and MEK inhibitors slowed tumor growth Targeted
Read more →Length of some regions of messenger RNA plays key role in regulating gene expression, cancer growth Role revealed for little-known process known as alternative polyadenylation First large-scale single-cancer analysis of alternative polyadenylation events Changes to length of certain RNA segments can be key prognostic indicator BUFFALO, N.Y.—
Read more →
English
Arabic
Bengali
Chinese (Simplified)
French
German
Hebrew
Japanese
Myanmar (Burmese)
Russian
Somali
Spanish
Sudanese
Swahili
Thai
Vietnamese
Xhosa
Yiddish